Fear of progression in parents of childhood cancer survivors: prevalence and associated factors.

Szczegóły
Abstrakt

Tytuł:: Fear of progression in parents of childhood cancer survivors: prevalence and associated factors.
Autorzy:: Peikert ML; Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Inhestern L; Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. .
Krauth KA; Department of Pediatrics, Pediatric Hematology and Oncology, Klinik Bad Oexen, Oexen 27, 32549, Bad Oeynhausen, Germany.
Escherich G; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Kandels D; Swabian Children's Cancer Center, Medical Faculty, University of Augsburg, Stenglinstraße 2, 86156, Augsburg, Germany.
Schiekiera LJ; Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Bergelt C; Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Źródło:: Journal of cancer survivorship : research and practice [J Cancer Surviv] 2022 Aug; Vol. 16 (4), pp. 823-833. Date of Electronic Publication: 2021 Jul 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Original Publication: New York, N.Y. : Springer Science + Business Media, c2007-
MeSH Terms:: Cancer Survivors*
Leukemia*
Neoplasms*/psychology
Adult ; Child ; Disease Progression ; Fear ; Humans ; Parents/psychology ; Prevalence ; Quality of Life/psychology
References:: Psychooncology. 2016 Jul;25(7):808-14. (PMID: 26477788)
Pediatr Blood Cancer. 2011 Apr;56(4):524-31. (PMID: 21298736)
Psychooncology. 2007 Mar;16(3):214-23. (PMID: 16906624)
Health Qual Life Outcomes. 2011 Nov 23;9:102. (PMID: 22111939)
J Psychosom Res. 2018 Nov;114:18-24. (PMID: 30314574)
J Gen Intern Med. 2001 Sep;16(9):606-13. (PMID: 11556941)
Acta Oncol. 2013 Aug;52(6):1102-9. (PMID: 23384721)
Psychooncology. 2019 Sep;28(9):1901-1909. (PMID: 31276614)
Cancer Nurs. 2008 Jul-Aug;31(4):292-301. (PMID: 18600116)
PLoS One. 2016 Jun 07;11(6):e0157076. (PMID: 27272318)
Health Qual Life Outcomes. 2009 Aug 26;7:77. (PMID: 19709410)
Support Care Cancer. 2015 Jun;23(6):1579-87. (PMID: 25412727)
J Pediatr Oncol Nurs. 2017 Sep/Oct;34(5):358-366. (PMID: 28443699)
Klin Padiatr. 2015 May;227(3):151-6. (PMID: 25811743)
Psychother Psychosom Med Psychol. 2012 Sep-Oct;62(9-10):344-51. (PMID: 23027388)
J Psychosoc Oncol. 2007;25(3):113-22. (PMID: 19341017)
Recent Results Cancer Res. 2018;210:13-33. (PMID: 28924677)
Psychooncology. 2020 Feb;29(2):430-436. (PMID: 31713279)
Psychooncology. 2013 Jan;22(1):1-11. (PMID: 22232030)
Behav Med. 2011 Jul;37(3):95-104. (PMID: 21895427)
J Psychosoc Oncol. 2021;39(1):89-104. (PMID: 32589114)
Cancer Treat Rev. 2010 Jun;36(4):277-85. (PMID: 20231056)
Fam Process. 2020 Sep;59(3):1225-1242. (PMID: 31408204)
Ann Intern Med. 2007 Oct 16;147(8):573-7. (PMID: 17938396)
J Affect Disord. 2004 Jul;81(1):61-6. (PMID: 15183601)
BMJ Open. 2020 Mar 8;10(3):e033730. (PMID: 32152163)
J Cancer Surviv. 2013 Sep;7(3):300-22. (PMID: 23475398)
Z Psychosom Med Psychother. 2006;52(3):274-88. (PMID: 17156600)
Klin Padiatr. 2018 Apr;230(3):130-137. (PMID: 29672778)
Support Care Cancer. 2010 Apr;18(4):471-9. (PMID: 19865833)
PLoS One. 2014 Jul 24;9(7):e103340. (PMID: 25058607)
Psychooncology. 2020 Nov;29(11):1959-1967. (PMID: 33068463)
Psychooncology. 2020 Oct;29(10):1678-1685. (PMID: 32779255)
Psychooncology. 2014 May;23(5):547-54. (PMID: 24293081)
BMJ Open. 2017 Aug 11;7(8):e014505. (PMID: 28801389)
J Psychosom Res. 2018 Apr;107:7-13. (PMID: 29502766)
J Psychosom Res. 2017 Feb;93:110-117. (PMID: 28107886)
Gen Hosp Psychiatry. 2006 Jan-Feb;28(1):71-7. (PMID: 16377369)
Psychother Psychosom. 2010;79(1):31-8. (PMID: 19887889)
J Adv Nurs. 2002 Jun;38(6):598-606. (PMID: 12067399)
J Pediatr Psychol. 2004 Apr-May;29(3):211-9. (PMID: 15131138)
Contributed Indexing:: Keywords: Cancer; Fear; Parents; Pediatrics; Psycho-oncology; Survivors
Entry Date(s):: Date Created: 20210724 Date Completed: 20220722 Latest Revision: 20220922
Update Code:: 20240105
PubMed Central ID:: PMC9300493
DOI:: 10.1007/s11764-021-01076-w
PMID:: 34302272
: Czasopismo naukowe

Full Text Finder

Purpose: Recent research demonstrated that fear of progression (FoP) is a major burden for adult cancer survivors. However, knowledge on FoP in parents of childhood cancer survivors is scarce. This study aimed to determine the proportion of parents who show dysfunctional levels of FoP, to investigate gender differences, and to examine factors associated with FoP in mothers and fathers.
Methods: Five hundred sixteen parents of pediatric cancer survivors (aged 0-17 years at diagnosis of leukemia or central nervous system (CNS) tumor) were consecutively recruited after the end of intensive cancer treatment. We conducted hierarchical multiple regression analyses for mothers and fathers and integrated parent-, patient-, and family-related factors in the models.
Results: Significantly more mothers (54%) than fathers (41%) suffered from dysfunctional levels of FoP. Maternal FoP was significantly associated with depression, a medical coping style, a child diagnosed with a CNS tumor in comparison to leukemia, and lower family functioning (adjusted R 2 = .30, p < .001). Paternal FoP was significantly associated with a lower level of education, depression, a family coping style, a child diagnosed with a CNS tumor in comparison to leukemia, and fewer siblings (adjusted R 2 = .48, p < .001).
Conclusions: FoP represents a great burden for parents of pediatric cancer survivors. We identified associated factors of parental FoP. Some of these factors can be targeted by health care professionals within psychosocial interventions and others can provide an indication for an increased risk for higher levels of FoP.
Implications for Cancer Survivors: Psychosocial support targeting FoP in parents of childhood cancer survivors is highly indicated.
(© 2021. The Author(s).)

Informacja